News | December 26, 2023
Astellas completes acquisition of Propella Therapeutics
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
Softovac Liquifibre expands the Softovac product portfolio and provides a choice for consumers who prefer time-tested Ayurvedic ingredients
The World Homoeopathy Day commemorates the birth anniversary of Dr Samuel Hahnemann on 10th of April
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Eris Lifesciences enters into term loan agreement with Citi Bank
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
_256_384.jpeg)
Launched Pathology Laboratory in Vijayawada offering a wide range of best-in-class diagnostic services with over 2500+ tests
Subscribe To Our Newsletter & Stay Updated
